Effects of luteinising-hormone-releasing hormone on nervous-system tumours.
J C
JC
van Groeninghen
L
L
Kiesel
D
D
Winkler
M
M
Zwirner
D001921:Brain / Q000473:pathology; D001932:Brain Neoplasms / Q000473:pathology* / Q000556:secondary; D002064:Buserelin; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000556:secondary; D002817:Chordoma / Q000473:pathology; D005909:Glioblastoma / Q000473:pathology; D005910:Glioma / Q000473:pathology; D007987:Gonadotropin-Releasing Hormone / Q000032:analysis*; D006801:Humans; D007457:Iodine Radioisotopes; D008175:Lung Neoplasms / Q000473:pathology; D008579:Meningioma / Q000473:pathology; D011374:Progesterone / Q000032:analysis; D019275:Radiopharmaceuticals; D011966:Receptors, LHRH / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis; D013120:Spinal Cord Neoplasms / Q000473:pathology*
D007457:Iodine Radioisotopes; D019275:Radiopharmaceuticals; D011966:Receptors, LHRH; D011980:Receptors, Progesterone; D007987:Gonadotropin-Releasing Hormone; D011374:Progesterone; D002064:Buserelin